AEYE-DS
Diabetic Retinopathy Screening
ApprovedActive
Key Facts
About AEYE Health
AEYE Health is a US-Israeli company, founded in 2018, that has commercialized an FDA-cleared, autonomous AI diagnostic system for diabetic retinopathy screening. Its solution enables rapid, on-the-spot screening in primary care settings using portable or desktop cameras, addressing the significant care gap in annual diabetic eye exams. The company is leveraging its core AI technology to build a comprehensive screening platform for multiple diseases, positioning itself at the intersection of ophthalmology, primary care, and predictive health analytics.
View full company profileTherapeutic Areas
Other Diabetic Retinopathy Screening Drugs
| Drug | Company | Phase |
|---|---|---|
| AI Fundus Camera System | VivaVision Biotech | Commercial |